Regresar

SKIN REACTIONS DEVELOPED UPON ADMINISTRATION OF THE COVID-19 VACCINE

Abstract:

Since the discovery of the new betacoronavirus, SARS-Cov-2, the description of skin lesions, considered an essential diagnostic and prognostic factor was initiated to anticipate the level of risk and severity of the dermatological sequelae that a person can manifest when suffering from Covid-19. Due to international initiatives, a vaccine against this disease was obtained in record time. However, the vaccines have presented side effects different from those pbkp_redicted in preclinical phases, without meaning that they are defective since this is expected behavior. Reports made after the licensing of the Pfizer and Moderna vaccines ratify the data presented in their respective clinical studies in which they indicate that the most frequent adverse cutaneous events are localized reactions. The present article describes the cutaneous reactions that developed when administering the vaccine against Covid-19 to facilitate its diagnosis.